510(k) K213396
K213396 is an FDA 510(k) premarket notification submitted by Helena Laboratories, Corp. for the device "SPIFE A1AT kit". The FDA issued a decision of Substantially Equivalent on Oct 13, 2022. The device falls under product code OBZ (Alpha-1-Antitrypsin Kit, Qualitative Phenotype), a Class II device regulated under 21 CFR 866.5130. Helena Laboratories, Corp. has 281 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 13, 2022
- Date Received
- Oct 18, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Alpha-1-Antitrypsin Kit, Qualitative Phenotype
- Device Class
- Class II
- Regulation Number
- 866.5130
- Review Panel
- IM
- Submission Type
- 510(k)
The alpha-1-antitrypsin qualitative phenotype test result is used as an aid in the diagnosis of alpha-1-antitrypsin deficiency in conjunction with clinical and other laboratory findings. For in vitro diagnostic use only.
Need the full FDA record for Helena Laboratories, Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.